Sarcopenia and nervous system disorders.

Rosenberg I (1989) Epidemiologic and methodologic problems in determining nutritional status of older persons. Am J Clin Nutr 50(5):1121–1235

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423. https://doi.org/10.1093/ageing/afq034

doi: 10.1093/ageing/afq034 pubmed: 20392703 pmcid: 2886201

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2 (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16–31. https://doi.org/10.1093/ageing/afy169

doi: 10.1093/ageing/afy169 pubmed: 30312372

Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O et al (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15(2):95–101. https://doi.org/10.1016/j.jamda.2013.11.025

doi: 10.1016/j.jamda.2013.11.025 pubmed: 24461239

Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, Ferrucci L, Guralnik JM, Fragala MS, Kenny AM et al (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol 69(5):547–558. https://doi.org/10.1093/gerona/glu010

doi: 10.1093/gerona/glu010

Petermann-Rocha F, Balntzi V, Gray SR, Lara J, Ho FK, Pell JP, Celis-Morales C (2022) Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 13(1):86–99. https://doi.org/10.1002/jcsm.12783

doi: 10.1002/jcsm.12783 pubmed: 34816624

Cruz-Jentoft AJ, Sayer AA (2019) Sarcopenia. Lancet (London, England) 393(10191):2636–2646. https://doi.org/10.1016/S0140-6736(19)31138-9

doi: 10.1016/S0140-6736(19)31138-9

Clark BC, Carson RG (2021) Sarcopenia and neuroscience: learning to communicate. J Gerontol 76(10):1882–1890. https://doi.org/10.1093/gerona/glab098

doi: 10.1093/gerona/glab098

Kara M, Özçakar L, Kaymak B, Ata AM, Frontera W (2020) A “Neuromuscular Look” to sarcopenia: Is it a movement disorder? J Rehabil Med 52(4):jrm00042. https://doi.org/10.2340/16501977-2672

doi: 10.2340/16501977-2672 pubmed: 32253444

Moreira-Pais A, Ferreira R, Oliveira PA, Duarte JA (2022) A neuromuscular perspective of sarcopenia pathogenesis: deciphering the signaling pathways involved. GeroScience. https://doi.org/10.1007/s11357-021-00510-2

doi: 10.1007/s11357-021-00510-2 pubmed: 34981273 pmcid: 9213593

Mas MF, González J, Frontera WR (2020) Stroke and sarcopenia. Curr Phys Med Rehabil Rep 8(4):452–460. https://doi.org/10.1007/s40141-020-00284-2

doi: 10.1007/s40141-020-00284-2 pubmed: 33777503 pmcid: 7990034

He N, Zhang Y, Zhang L, Zhang S, Ye H (2021) Relationship between sarcopenia and cardiovascular diseases in the elderly: an overview. Front Cardiovasc Med 8:743710. https://doi.org/10.3389/fcvm.2021.743710

doi: 10.3389/fcvm.2021.743710 pubmed: 34957238 pmcid: 8695853

Sasaki KI, Fukumoto Y (2022) Sarcopenia as a comorbidity of cardiovascular disease. J Cardiol 79(5):596–604. https://doi.org/10.1016/j.jjcc.2021.10.013

doi: 10.1016/j.jjcc.2021.10.013 pubmed: 34906433

Gueugneau M, Coudy-Gandilhon C, Meunier B, Combaret L, Taillandier D, Polge C, Attaix D, Roche F, Féasson L, Barthélémy JC, Béchet D (2016) Lower skeletal muscle capillarization in hypertensive elderly men. Exp Gerontol 76:80–88. https://doi.org/10.1016/j.exger.2016.01.013

doi: 10.1016/j.exger.2016.01.013 pubmed: 26826452

Miloserdov MA, Maslova NN, Erohina AS, Evseev AV, Maslov NE (2022) Stroke risk stratification in elderly patients with comorbid sarcopenia and atherosclerosis. Zh Nevrol Psikhiatr Im S S Korsakova 122(3. Vyp. 2):31–37. https://doi.org/10.1716/jnevro202212203231 (Russian)

doi: 10.1716/jnevro202212203231 pubmed: 35318840

Harris ML, Polkey MI, Bath PM, Moxham J (2001) Quadriceps muscle weakness following acute hemiplegic stroke. Clin Rehabil 15(3):274–281. https://doi.org/10.1191/026921501669958740

doi: 10.1191/026921501669958740 pubmed: 11386397

Scherbakov N, von Haehling S, Anker SD, Dirnagl U, Doehner W (2013) Stroke induced Sarcopenia: muscle wasting and disability after stroke. Int J Cardiol 170(2):89–94. https://doi.org/10.1016/j.ijcard.2013.10.031

doi: 10.1016/j.ijcard.2013.10.031 pubmed: 24231058

Ryan AS, Ivey FM, Serra MC, Hartstein J, Hafer-Macko CE (2017) Sarcopenia and physical function in middle-aged and older stroke survivors. Arch Phys Med Rehabil 98(3):495–499. https://doi.org/10.1016/j.apmr.2016.07.015

doi: 10.1016/j.apmr.2016.07.015 pubmed: 27530769

Lee H, Lee IH, Heo J, Baik M, Park H, Lee HS, Nam HS, Kim YD (2022) Impact of sarcopenia on functional outcomes among patients with mild acute ischemic stroke and transient ischemic attack: a retrospective study. Front Neurol 13:841945. https://doi.org/10.3389/fneur.2022.841945

doi: 10.3389/fneur.2022.841945 pubmed: 35370897 pmcid: 8964497

Nozoe M, Kanai M, Kubo H, Yamamoto M, Shimada S, Mase K (2019) Prestroke sarcopenia and stroke severity in elderly patients with acute stroke. J Stroke Cerebrovascular Dis 28(8):2228–2231. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.05.001

doi: 10.1016/j.jstrokecerebrovasdis.2019.05.001

Park JG, Lee KW, Kim SB, Lee JH, Kim YH (2019) Effect of decreased skeletal muscle index and hand grip strength on functional recovery in subacute ambulatory stroke patients. Ann Rehabil Med 43(5):535–543. https://doi.org/10.5535/arm.2019.43.5.535

doi: 10.5535/arm.2019.43.5.535 pubmed: 31693843 pmcid: 6835132

Sun Y, Zehr EP (2019) Training-induced neural plasticity and strength are amplified after stroke. Exerc Sport Sci Rev 47(4):223–229. https://doi.org/10.1249/JES.0000000000000199

doi: 10.1249/JES.0000000000000199 pubmed: 31283528 pmcid: 6887626

Davalos D, Akassoglou K (2012) Fibrinogen as a key regulator of inflammation in disease. Seminars Immunopathol 34(1):43–62. https://doi.org/10.1007/s00281-011-0290-8

doi: 10.1007/s00281-011-0290-8

Shenhar-Tsarfaty S, Ben Assayag E, Bova I, Shopin L, Cohen M, Berliner S, Shapira I, Bornstein NM (2008) Persistent hyperfibrinogenemia in acute ischemic stroke/transient ischemic attack (TIA). Thromb Haemost 99(1):169–173. https://doi.org/10.1160/TH07-08-0484

doi: 10.1160/TH07-08-0484 pubmed: 18217150

Pedersen A, Redfors P, Lundberg L, Gils A, Declerck PJ, Nilsson S, Jood K, Jern C (2016) Haemostatic biomarkers are associated with long-term recurrent vascular events after ischaemic stroke. Thromb Haemost 116(3):537–543. https://doi.org/10.1160/TH15-12-0938

doi: 10.1160/TH15-12-0938 pubmed: 27357914

Hou HQ, Xiang XL, Pan YS, Zhang QH, Li H, Meng X, Wang YJ (2021) Baseline or 90-day fibrinogen levels and long-term outcomes after ischemic stroke or TIA: results from the China national stroke registry III. Atherosclerosis 337:35–41. https://doi.org/10.1016/j.atherosclerosis.2021.10.002

doi: 10.1016/j.atherosclerosis.2021.10.002 pubmed: 34757269

Chen JL, Chen DM, Luo C, Sun Y, Zhao YX, Huang CQ, Zhao KX, Xiao Q (2021) Fibrinogen, fibrin degradation products and risk of sarcopenia. Clin Nutr (Edinburgh, Scotland) 40(8):4830–4837. https://doi.org/10.1016/j.clnu.2021.06.031

doi: 10.1016/j.clnu.2021.06.031

Schinwelski MJ, Sitek EJ, Wąż P, Sławek JW (2019) Prevalence and predictors of post-stroke spasticity and its impact on daily living and quality of life. Neurol Neurochir Pol 53(6):449–457. https://doi.org/10.5603/PJNNS.a2019.0067

doi: 10.5603/PJNNS.a2019.0067 pubmed: 31845749

Lieber RL, Fridén J (2019) Muscle contracture and passive mechanics in cerebral palsy. J Appl Physiol (Bethesda, Md.: 1985) 126(5):1492–1501. https://doi.org/10.1152/japplphysiol.00278.2018

doi: 10.1152/japplphysiol.00278.2018

Kobuchi R, Okuno K, Kusunoki T, Inoue T, Takahashi K (2020) The relationship between sarcopenia and oral sarcopenia in elderly people. J Oral Rehabil 47(5):636–642. https://doi.org/10.1111/joor.12948

doi: 10.1111/joor.12948 pubmed: 32072652

Amarasekera AT, Chang D, Schwarz P, Tan TC (2021) Vascular endothelial dysfunction may be an early predictor of physical frailty and sarcopenia: a meta-analysis of available data from observational studies. Exp Gerontol 148:111260. https://doi.org/10.1016/j.exger.2021.111260

doi: 10.1016/j.exger.2021.111260 pubmed: 33571660

Ganapathy A, Nieves JW (2020) Nutrition and Sarcopenia—what do we know? Nutrients 12(6):1755. https://doi.org/10.3390/nu12061755

doi: 10.3390/nu12061755 pmcid: 7353446

Isanejad M, Sirola J, Mursu J, Rikkonen T, Kröger H, Tuppurainen M, Erkkilä AT (2018) Association of the Baltic Sea and Mediterranean diets with indices of sarcopenia in elderly women, OSPTRE-FPS study. Eur J Nutr 57(4):1435–1448. https://doi.org/10.1007/s00394-017-1422-2

doi: 10.1007/s00394-017-1422-2 pubmed: 28303397

Spira D, Walston J, Buchmann N, Nikolov J, Demuth I, Steinhagen-Thiessen E, Eckardt R, Norman K (2016) Angiotensin-converting enzyme inhibitors and parameters of sarcopenia: relation to muscle mass, strength and function: data from the berlin aging study-II (BASE-II). Drugs Aging 33(11):829–837. https://doi.org/10.1007/s40266-016-0396-8

doi: 10.1007/s40266-016-0396-8 pubmed: 27665105

Vetrano DL, Pisciotta MS, Laudisio A, Lo Monaco MR, Onder G, Brandi V, Fusco D, Di Capua B, Ricciardi D et al (2018) Sarcopenia in Parkinson disease: comparison of different criteria and association with disease severity. J Am Med Direct Assoc 19(6):523–527. https://doi.org/10.1016/j.jamda.2017.12.005

doi: 10.1016/j.jamda.2017.12.005

Cai Y, Feng F, Wei Q, Jiang Z, Ou R, Shang H (2021) Sarcopenia in patients with Parkinson’s disease: a systematic review and meta-analysis. Front Neurol 12:598035. https://doi.org/10.3389/fneur.2021.598035

doi: 10.3389/fneur.2021.598035 pubmed: 33746871 pmcid: 7973225

Peball M, Mahlknecht P, Werkmann M, Marini K, Murr F, Herzmann H, Stockner H, de Marzi R, Heim B, Djamshidian A et al (2019) Prevalence and associated factors of sarcopenia and frailty in Parkinson’s disease: a cross-sectional study. Gerontology 65(3):216–228. https://doi.org/10.1159/000492572。

doi: 10.1159/000492572。 pubmed: 30199864

Lima DP, de Almeida SB, Bonfadini JC, de Luna JRG, de Alencar MS, Pinheiro Neto EB et al (2020) Clinical correlates of sarcopenia and falls in Parkinson’s disease. PloS One 15(3):e0227238. https://doi.org/10.1371/journal.pone.0227238

doi: 10.1371/journal.pone.0227238 pubmed: 32191713 pmcid: 7082018

Chung SJ, Kim YJ, Yoo HS, Jung JH, Baik K, Lee HS, Lee YH, Hong JM, Sohn YH, Lee PH (2021) Temporalis muscle thickness as an indicator of sarcopenia is associated with long-term motor outcomes in Parkinson’s disease. J Gerontol 76(12):2242–2248. https://doi.org/10.1093/gerona/glab082

doi: 10.1093/gerona/glab082

Krenovsky JP, Bötzel K, Ceballos-Baumann A, Fietzek UM, Schoser B, Maetzler W, Ferrari U, Drey M (2020) Interrelation between sarcopenia and the number of motor neurons in patients with parkinsonian syndromes. Gerontology 66(4):409–415. https://doi.org/10.1159/000505590

doi: 10.1159/000505590 pubmed: 32088717

Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. https://doi.org/10.1038/s41577-022-00684-6

doi: 10.1038/s41577-022-00684-6 pubmed: 35246670 pmcid: 8895080

Pan L, Xie W, Fu X, Lu W, Jin H, Lai J, Zhang A, Yu Y, Li Y, Xiao W (2021) Inflammation and sarcopenia: a focus on circulating inflammatory cytokines. Exp Gerontol 154:111544. https://doi.org/10.1016/j.exger.2021.111544

doi: 10.1016/j.exger.2021.111544 pubmed: 34478826

Wu YN, Chen MH, Chiang PL, Lu CH, Chen HL, Yu CC, Chen YS, Chang YY, Lin WC (2020) Associations between brain structural damage and core muscle loss in patients with Parkinson’s disease. J Clin Med 9(1):239. https://doi.org/10.3390/jcm9010239

doi: 10.3390/jcm9010239 pmcid: 7019762

Lee CY, Chen HL, Chen PC, Chen YS, Chiang PL, Wang CK, Lu CH, Chen MH, Chou KH, Huang YC, Lin WC (2019) Correlation between executive network integrity and sarcopenia in patients with Parkinson’s disease. Int J Environ Res Public Health 16(24):4884. https://doi.org/10.3390/ijerph16244884

doi: 10.3390/ijerph16244884 pmcid: 6950743

Umay E, Yigman ZA, Ozturk EA, Gundogdu I, Koçer BG (2021) Is dysphagia in older patients with Parkinson’s disease associated with sarcopenia? J Nutr Health Aging 25(6):742–747. https://doi.org/10.1007/s12603-021-1618-2

doi: 10.1007/s12603-021-1618-2 pubmed: 34179927

Pradhan S, Kelly VE (2019) Quantifying physical activity in early Parkinson disease using a commercial activity monitor. Parkinsonism Relat Disord 66:171–175. https://doi.org/10.1016/j.parkreldis.2019.08.001

doi: 10.1016/j.parkreldis.2019.08.001 pubmed: 31420310 pmcid: 7065569

Rivadeneyra J, Verhagen O, Bartulos M, Mariscal-Pérez N, Collazo C, Garcia-Bustillo A, Calvo S, Cubo E (2021) The impact of dietary intake and physical activity on body composition in Parkinson’s disease. Move Disord Clin Pract 8(6):896–903. https://doi.org/10.1002/mdc3.13263

doi: 10.1002/mdc3.13263

Karim A, Iqbal MS, Muhammad T, Qaisar R (2022) Evaluation of sarcopenia using biomarkers of the neuromuscular junction in Parkinson’s disease. J Mol Neurosci 72(4):820–829. https://doi.org/10.1007/s12031-022-01970-7

doi: 10.1007/s12031-022-01970-7 pubmed: 35044622

Ramoo K, Hairi NN, Yahya A, Choo WY, Hairi FM, Peramalah D, Kandiben S, Bulgiba A, Ali ZM, Razak IA et al (2022) Longitudinal association between sarcopenia and cognitive impairment among older adults in rural Malaysia. Int J Environ Res Public Health 19(8):4723. https://doi.org/10.3390/ijerph19084723

doi: 10.3390/ijerph19084723 pubmed: 35457592 pmcid: 9025848

de Souza LF, Fontanela LC, Gonçalves C, Mendrano AL, Freitas MA, Danielewicz AL, de Avelar NCP (2021) Cognitive and behavioral factors associated to probable sarcopenia in community-dwelling older adults. Exp Aging Res. https://doi.org/10.1080/0361073X.2021.1939564

doi: 10.1080/0361073X.2021.1939564 pubmed: 34170210

Cipolli GC, Aprahamian I, Borim F, Falcão D, Cachioni M, Melo RC, Batistoni S, Neri AL, Yassuda MS (2021) Probable sarcopenia is associated with cognitive impairment among community-dwelling older adults: results from the FIBRA study. Arq Neuropsiquiatr 79(5):376–383

doi: 10.1590/0004-282x-anp-2020-0186

Zammit AR, Piccinin AM, Duggan EC, Koval A, Clouston S, Robitaille A, Brown CL, Handschuh P, Wu C, Jarry V, Finkel D et al (2021) A coordinated multi-study analysis of the longitudinal association between handgrip strength and cognitive function in older adults. J Gerontol 76(2):229–241. https://doi.org/10.1093/geronb/gbz072

doi: 10.1093/geronb/gbz072

Rasmussen L, Caspi A, Ambler A, Broadbent JM, Cohen HJ, d’Arbeloff T, Elliott M, Hancox RJ, Harrington H, Hogan S et al (2019) Association of neurocognitive and physical function with gait speed in midlife. JAMA Netw Open 2(10):e1913123. https://doi.org/10.1001/jamanetworkopen.2019.13123

doi: 10.1001/jamanetworkopen.2019.13123 pubmed: 31603488 pmcid: 6804027

Chou MY, Nishita Y, Nakagawa T, Tange C, Tomida M, Shimokata H, Otsuka R, Chen LK, Arai H (2019) Role of gait speed and grip strength in predicting 10-year cognitive decline among community-dwelling older people. BMC Geriatr 19(1):186. https://doi.org/10.1186/s12877-019-1199-7

doi: 10.1186/s12877-019-1199-7 pubmed: 31277579 pmcid: 6612180

Beeri MS, Leugrans SE, Delbono O, Bennett DA, Buchman AS (2021) Sarcopenia is associated with incident Alzheimer’s dementia, mild cognitive impairment, and cognitive decline. J Am Geriatr Soc 69(7):1826–1835. https://doi.org/10.1111/jgs.17206

doi: 10.1111/jgs.17206 pubmed: 33954985 pmcid: 8286176

Salinas-Rodríguez A, Palazuelos-González R, Rivera-Almaraz A, Manrique-Espinoza B (2021) Longitudinal association of sarcopenia and mild cognitive impairment among older Mexican adults. J Cachexia Sarcopenia Muscle 12(6):1848–1859. https://doi.org/10.1002/jcsm.12787

doi: 10.1002/jcsm.12787 pubmed: 34535964 pmcid: 8718052

Zhang T, Zhang Y, Lv Z, Xiang J (2022) Sarcopenia and motoric cognitive risk syndrome: a moderated mediation model. BMC Geriatr 22(1):141. https://doi.org/10.1186/s12877-022-02802-4

doi: 10.1186/s12877-022-02802-4 pubmed: 35183116 pmcid: 8857782

Hsu YH, Liang CK, Chou MY, Wang YC, Liao MC, Chang WC, Hsiao CC, Lai PH, Lin YT (2021) Sarcopenia is independently associated with parietal atrophy in older adults. Exp Gerontol 151:111402. https://doi.org/10.1016/j.exger.2021.111402

doi: 10.1016/j.exger.2021.111402 pubmed: 33984449

Yu JH, Kim R, Jung JM, Park SY, Lee DY, Cho HJ, Kim NH, Yoo HJ, Seo JA, Kim SG, Choi KM, Baik SH, Shin C, Kim NH (2021) Sarcopenia is associated with decreased gray matter volume in the parietal lobe: a longitudinal cohort study. BMC Geriatr 21(1):622. https://doi.org/10.1186/s12877-021-02581-4

doi: 10.1186/s12877-021-02581-4 pubmed: 34727885 pmcid: 8565062

Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, Kim JS, Heo S, Alves H, White SM, Wojcicki TR et al (2011) Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA 108(7):3017–3022. https://doi.org/10.1073/pnas.1015950108

doi: 10.1073/pnas.1015950108 pubmed: 21282661 pmcid: 3041121

Pedersen BK (2019) Physical activity and muscle-brain crosstalk. Nat Rev Endocrinol 15(7):383–392. https://doi.org/10.1038/s41574-019-0174-x

doi: 10.1038/s41574-019-0174-x pubmed: 30837717

Ogawa Y, Kaneko Y, Sato T, Shimizu S, Kanetaka H, Hanyu H (2018) Sarcopenia and muscle functions at various stages of Alzheimer disease. Front Neurol 9:710. https://doi.org/10.3389/fneur.2018.00710

doi: 10.3389/fneur.2018.00710 pubmed: 30210435 pmcid: 6121095

Kuo YM, Kokjohn TA, Watson MD, Woods AS, Cotter RJ, Sue LI, Kalback WM, Emmerling MR, Beach TG, Roher AE (2000) Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism. Am J Pathol 156(3):797–805. https://doi.org/10.1016/s0002-9440(10)64947-4

doi: 10.1016/s0002-9440(10)64947-4 pubmed: 10702395 pmcid: 1876838

Ohkawara B, Ito M, Ohno K (2021) Secreted signaling molecules at the neuromuscular junction in physiology and pathology. Int J Mol Sci 22(5):2455. https://doi.org/10.3390/ijms22052455

doi: 10.3390/ijms22052455 pubmed: 33671084 pmcid: 7957818

Torcinaro A, Ricci V, Strimpakos G, De Santa F, Middei S (2021) Peripheral nerve impairment in a mouse model of Alzheimer’s disease. Brain Sci 11(9):1245. https://doi.org/10.3390/brainsci11091245

doi: 10.3390/brainsci11091245 pubmed: 34573265 pmcid: 8465822

Chen X, Miller NM, Afghah Z, Geiger JD (2019) Development of AD-like pathology in skeletal muscle. J Parkinson’s Dis Alzheimer’s Dis. https://doi.org/10.13188/2376-922x.1000028

doi: 10.13188/2376-922x.1000028

Sui SX, Williams LJ, Holloway-Kew KL, Hyde NK, Pasco JA (2020) Skeletal muscle health and cognitive function: a narrative review. Int J Mol Sci 22(1):255. https://doi.org/10.3390/ijms22010255

doi: 10.3390/ijms22010255 pmcid: 7795998

Beaudart C, Sanchez-Rodriguez D, Locquet M, Reginster JY, Lengelé L, Bruyère O (2019) Malnutrition as a strong predictor of the onset of sarcopenia. Nutrients 11(12):2883. https://doi.org/10.3390/nu11122883

doi: 10.3390/nu11122883 pmcid: 6950107

Gómez-Gómez ME, Zapico SC (2019) Frailty, cognitive decline, neurodegenerative diseases and nutrition interventions. Int J Mol Sci 20(11):2842. https://doi.org/10.3390/ijms20112842

doi: 10.3390/ijms20112842 pmcid: 6600148

Hu F, Liu H, Liu X, Jia S, Zhao W, Zhou L, Zhao Y, Hou L, Xia X, Dong B (2021) Nutritional status mediates the relationship between sarcopenia and cognitive impairment: findings from the WCHAT study. Aging Clin Exp Res 33(12):3215–3222. https://doi.org/10.1007/s40520-021-01883-2

doi: 10.1007/s40520-021-01883-2 pubmed: 34028708 pmcid: 8141547

Taylor MK, Mahnken JD, Sullivan DK (2020) NHANES 2011–2014 reveals cognition of US older adults may benefit from better adaptation to the Mediterranean diet. Nutrients 12(7):1929. https://doi.org/10.3390/nu12071929

doi: 10.3390/nu12071929 pmcid: 7399952

Ansari SA, Emerald BS (2019) The role of insulin resistance and protein O-GlcNAcylation in neurodegeneration. Front Neurosci 13:473. https://doi.org/10.3389/fnins.2019.00473

doi: 10.3389/fnins.2019.00473 pubmed: 31143098 pmcid: 6521730

Jo D, Yoon G, Kim OY, Song J (2022) A new paradigm in sarcopenia: Cognitive impairment caused by imbalanced myokine secretion and vascular dysfunction. Biomed Pharmacother 147:112636. https://doi.org/10.1016/j.biopha.2022.112636

doi: 10.1016/j.biopha.2022.112636 pubmed: 35051857

Nagase T, Tohda C (2021) Skeletal muscle atrophy-induced hemopexin accelerates onset of cognitive impairment in Alzheimer’s disease. J Cachexia Sarcopenia Muscle 12(6):2199–2210. https://doi.org/10.1002/jcsm.12830

doi: 10.1002/jcsm.12830 pubmed: 34658156 pmcid: 8718090

Dalle S, Rossmeislova L, Koppo K (2017) The role of inflammation in age-related sarcopenia. Front Physiol 8:1045. https://doi.org/10.3389/fphys.2017.01045

doi: 10.3389/fphys.2017.01045 pubmed: 29311975 pmcid: 5733049

Kimura N, Aso Y, Yabuuchi K, Ishibashi M, Hori D, Sasaki Y, Nakamichi A, Uesugi S, Fujioka H, Iwao S et al (2019) Modifiable lifestyle factors and cognitive function in older people: a cross-sectional observational study. Front Neurol 10:401. https://doi.org/10.3389/fneur.2019.00401

doi: 10.3389/fneur.2019.00401 pubmed: 31068892 pmcid: 6491512

Gonzalez A, Simon F, Achiardi O, Vilos C, Cabrera D, Cabello-Verrugio C (2021) The critical role of oxidative stress in sarcopenic obesity. Oxid Med Cell Longev 2021:4493817. https://doi.org/10.1155/2021/4493817

doi: 10.1155/2021/4493817 pubmed: 34676021 pmcid: 8526202

Franzoni F, Scarfò G, Guidotti S, Fusi J, Asomov M, Pruneti C (2021) Oxidative stress and cognitive decline: the neuroprotective role of natural antioxidants. Front Neurosci 15:729757. https://doi.org/10.3389/fnins.2021.729757

doi: 10.3389/fnins.2021.729757 pubmed: 34720860 pmcid: 8548611

Sekhar RV (2021) GlyNAC supplementation improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, aging hallmarks, metabolic defects, muscle strength, cognitive decline, and body composition: implications for healthy aging. J Nutr 151(12):3606–3616. https://doi.org/10.1093/jn/nxab309

doi: 10.1093/jn/nxab309 pubmed: 34587244

Gariballa S, Alessa A (2020) Associations between low muscle mass, blood-borne nutritional status and mental health in older patients. BMC Nutr 6:6. https://doi.org/10.1186/s40795-019-0330-7

doi: 10.1186/s40795-019-0330-7 pubmed: 32190345 pmcid: 7066831

Huang CY, Hwang AC, Liu LK, Lee WJ, Chen LY, Peng LN, Lin MH, Chen LK (2016) Association of Dynapenia, Sarcopenia, and cognitive impairment among community-dwelling older Taiwanese. Rejuvenation Res 19(1):71–78. https://doi.org/10.1089/rej.2015.1710

doi: 10.1089/rej.2015.1710 pubmed: 26165544

Olgun Yazar H, Yazar T (2019) Prevalence of sarcopenia in patients with geriatric depression diagnosis. Ir J Med Sci 188(3):931–938. https://doi.org/10.1007/s11845-018-01957-7

doi: 10.1007/s11845-018-01957-7 pubmed: 30610679

Li Z, Tong X, Ma Y, Bao T, Yue J (2022) Prevalence of depression in patients with sarcopenia and correlation between the two diseases: systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 13(1):128–144. https://doi.org/10.1002/jcsm.12908

doi: 10.1002/jcsm.12908 pubmed: 34997702 pmcid: 8818614

Chen X, Guo J, Han P, Fu L, Jia L, Yu H, Yu X, Hou L, Wang L, Zhang W et al (2019) Twelve-month incidence of depressive symptoms in suburb-dwelling Chinese older adults: role of sarcopenia. J Am Med Dir Assoc 20(1):64–69. https://doi.org/10.1016/j.jamda.2018.07.017

doi: 10.1016/j.jamda.2018.07.017 pubmed: 30268631

Chen X, Han P, Yu X, Zhang Y, Song P, Liu Y, Jiang Z, Tao Z, Shen S, Wu Y et al (2021) Relationships between sarcopenia, depressive symptoms, and mild cognitive impairment in Chinese community-dwelling older adults. J Affect Disord 286:71–77. https://doi.org/10.1016/j.jad.2021.02.067

doi: 10.1016/j.jad.2021.02.067 pubmed: 33714172

Jin Y, Kang S, Kang H (2021) Individual and synergistic relationships of low muscle mass and low muscle function with depressive symptoms in Korean older adults. Int J Environ Res Public Health 18(19):10129. https://doi.org/10.3390/ijerph181910129

doi: 10.3390/ijerph181910129 pubmed: 34639432 pmcid: 8507727

Rana T, Behl T, Sehgal A, Srivastava P, Bungau S (2021) Unfolding the role of BDNF as a biomarker for treatment of depression. J Mol Neurosci 71(10):2008–2021. https://doi.org/10.1007/s12031-020-01754-x

doi: 10.1007/s12031-020-01754-x pubmed: 33230708

Gelle T, Samey RA, Plansont B, Bessette B, Jauberteau-Marchan MO, Lalloué F, Girard M (2021) BDNF and pro-BDNF in serum and exosomes in major depression: evolution after antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry 109:110229. https://doi.org/10.1016/j.pnpbp.2020.110229

doi: 10.1016/j.pnpbp.2020.110229 pubmed: 33358963

Burtscher J, Millet GP, Place N, Kayser B, Zanou N (2021) The muscle-brain axis and neurodegenerative diseases: the key role of mitochondria in exercise-induced neuroprotection. Int J Mol Sci 22(12):6479. https://doi.org/10.3390/ijms22126479

doi: 10.3390/ijms22126479 pubmed: 34204228 pmcid: 8235687

Miyazaki S, Iino N, Koda R, Narita I, Kaneko Y (2021) Brain-derived neurotrophic factor is associated with sarcopenia and frailty in Japanese hemodialysis patients. Geriatr Gerontol Int 21(1):27–33. https://doi.org/10.1111/ggi.14089

doi: 10.1111/ggi.14089 pubmed: 33215785

Chu AL, Hickman M, Steel N, Jones PB, Davey Smith G, Khandaker GM (2021) Inflammation and depression: a public health perspective. Brain Behav Immun 95:1–3. https://doi.org/10.1016/j.bbi.2021.04.015

doi: 10.1016/j.bbi.2021.04.015 pubmed: 33882327

Delibaş DH, Eşkut N, İlhan B, Erdoğan E, Top Kartı D, Yılmaz Küsbeci Ö, Bahat G (2021) Clarifying the relationship between sarcopenia and depression in geriatric outpatients. Aging Male 24(1):29–36. https://doi.org/10.1080/13685538.2021.1936482

doi: 10.1080/13685538.2021.1936482 pubmed: 34151708

Chen GQ, Wang GP, Lian Y (2022) Relationships between depressive symptoms, dietary inflammatory potential, and sarcopenia: mediation analyses. Front Nutr 9:844917. https://doi.org/10.3389/fnut.2022.844917

doi: 10.3389/fnut.2022.844917 pubmed: 35252313 pmcid: 8891449

Oliva Ramirez A, Keenan A, Kalau O, Worthington E, Cohen L, Singh S (2021) Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review. BMC Neurol 21(1):468. https://doi.org/10.1186/s12883-021-02396-1

doi: 10.1186/s12883-021-02396-1 pubmed: 34856949 pmcid: 8638268

Fortune J, Norris M, Stennett A, Kilbride C, Lavelle G, Hendrie W, Victor C, Ryan JM (2021) Patterns and correlates of sedentary behaviour among people with multiple sclerosis: a cross-sectional study. Sci Rep 11(1):20346. https://doi.org/10.1038/s41598-021-99631-z

doi: 10.1038/s41598-021-99631-z pubmed: 34645876 pmcid: 8514488

Yuksel H, Balaban M, Tan OO, Mungan S (2022) Sarcopenia in patients with multiple sclerosis. Multiple Sclerosis Relat Disord 58:103471. https://doi.org/10.1016/j.msard.2021.103471

doi: 10.1016/j.msard.2021.103471

Rudroff T, Kindred JH, Ketelhut NB (2016) Fatigue in multiple sclerosis: misconceptions and future research directions. Front Neurol 7:122. https://doi.org/10.3389/fneur.2016.00122

doi: 10.3389/fneur.2016.00122 pubmed: 27531990 pmcid: 4969300

Kalb R, Brown TR, Coote S, Costello K, Dalgas U, Garmon E, Giesser B, Halper J, Karpatkin H, Keller J et al (2020) Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course. Multiple Sclerosis (Houndmills, Basingstoke, England) 26(12):1459–1469. https://doi.org/10.1177/1352458520915629

doi: 10.1177/1352458520915629

Taul-Madsen L, Connolly L, Dennett R, Freeman J, Dalgas U, Hvid LG (2021) Is aerobic or resistance training the most effective exercise modality for improving lower extremity physical function and perceived fatigue in people with multiple sclerosis? A systematic review and meta-analysis. Arch Phys Med Rehabil 102(10):2032–2048. https://doi.org/10.1016/j.apmr.2021.03.026

doi: 10.1016/j.apmr.2021.03.026 pubmed: 33901439

Iyer SR, Shah SB, Lovering RM (2021) The neuromuscular junction: roles in aging and neuromuscular disease. Int J Mol Sci 22(15):8058. https://doi.org/10.3390/ijms22158058

doi: 10.3390/ijms22158058 pubmed: 34360831 pmcid: 8347593

Deschenes MR, Flannery R, Hawbaker A, Patek L, Mifsud M (2022) Adaptive remodeling of the neuromuscular junction with aging. Cells 11(7):1150. https://doi.org/10.3390/cells11071150

doi: 10.3390/cells11071150 pubmed: 35406714 pmcid: 8997609

Chang CC, Chen YK, Chiu HC, Yeh JH (2021) Assessment of sarcopenia and obesity in patients with myasthenia gravis using dual-energy x-ray absorptiometry: a cross-sectional study. J Personaliz Med 11(11):1139. https://doi.org/10.3390/jpm11111139

doi: 10.3390/jpm11111139

Qiao L, Zhang Y, Ban R, Lin Y, Pu C, Shi Q (2021) Muscular pathological features in patients with myasthenia gravis. Clin Neuropathol 40(6):319–327. https://doi.org/10.5414/NP301382

doi: 10.5414/NP301382 pubmed: 34236310

Velonakis G, Papadopoulos VE, Karavasilis E, Filippiadis DK, Zouvelou V (2021) MRI evidence of extraocular muscle atrophy and fatty replacement in myasthenia gravis. Neuroradiology 63(9):1531–1538. https://doi.org/10.1007/s00234-021-02753-4

doi: 10.1007/s00234-021-02753-4 pubmed: 34232334

Nakakubo S, Doi T, Tsutsumimoto K, Kurita S, Ishii H, Shimada H (2021) Sleep duration and progression to sarcopenia in Japanese community-dwelling older adults: a 4 year longitudinal study. J Cachexia Sarcopenia Muscle 12(4):1034–1041. https://doi.org/10.1002/jcsm.12735

doi: 10.1002/jcsm.12735 pubmed: 34190427 pmcid: 8350197

Smith L, Shin JI, Veronese N, Soysal P, López Sánchez GF, Pizzol D, Demurtas J, Tully MA, Barnett Y, Butler L, Koyanagi A (2022) Sleep duration and sarcopenia in adults aged ≥ 65 years from low and middle-income countries. Aging Clin Exp Res. https://doi.org/10.1007/s40520-022-02074-3

doi: 10.1007/s40520-022-02074-3 pubmed: 36136237

Rubio-Arias JÁ, Rodríguez-Fernández R, Andreu L, Martínez-Aranda LM, Martínez-Rodriguez A, Ramos-Campo DJ (2019) Effect of sleep quality on the prevalence of sarcopenia in older adults: a systematic review with meta-analysis. J Clin Med 8(12):2156. https://doi.org/10.3390/jcm8122156

doi: 10.3390/jcm8122156 pmcid: 6947616

Pourmotabbed A, Ghaedi E, Babaei A, Mohammadi H, Khazaie H, Jalili C, Symonds ME, Moradi S, Miraghajani M (2020) Sleep duration and sarcopenia risk: a systematic review and dose-response meta-analysis. Sleep Breat 24(4):1267–1278. https://doi.org/10.1007/s11325-019-01965-6

doi: 10.1007/s11325-019-01965-6

Huang WC, Lin CY, Togo F, Lai TF, Hsueh MC, Liao Y, Park H, Kumagai S (2022) Nonlinear associations between sleep patterns and sarcopenia risks in older adults. J Clin Sleep Med 18(3):731–738. https://doi.org/10.5664/jcsm.9698

doi: 10.5664/jcsm.9698 pubmed: 34608860

Szlejf C, Suemoto CK, Drager LF, Griep RH, Fonseca M, Diniz M, Lotufo PA, Benseãor IM (2021) Association of sleep disturbances with sarcopenia and its defining components: the ELSA-Brasil study. Brazil J Med Biol Res 54(12):e11539. https://doi.org/10.1590/1414-431X2021e11539

doi: 10.1590/1414-431X2021e11539

Saner NJ, Lee MJ, Pitchford NW, Kuang J, Roach GD, Garnham A, Stokes T, Phillips SM, Bishop DJ, Bartlett JD (2020) The effect of sleep restriction, with or without high-intensity interval exercise, on myofibrillar protein synthesis in healthy young men. J Physiol 598(8):1523–1536. https://doi.org/10.1113/JP278828

doi: 10.1113/JP278828 pubmed: 32078168

Mohammadi H, Rezaei M, Sharafkhaneh A, Khazaie H, Ghadami MR (2020) Serum testosterone/cortisol ratio in people with obstructive sleep apnea. J Clin Lab Anal 34(1):e23011. https://doi.org/10.1002/jcla.23011

doi: 10.1002/jcla.23011 pubmed: 31549459

Prokopidis K, Dionyssiotis Y (2021) Effects of sleep deprivation on sarcopenia and obesity: a narrative review of randomized controlled and crossover trials. J Frailty Sarcopenia Falls 6(2):50–56. https://doi.org/10.22540/JFSF-06-050

doi: 10.22540/JFSF-06-050 pubmed: 34131601 pmcid: 8173530

Padilla CJ, Harrigan ME, Harris H, Schwab JM, Rutkove SB, Rich MM, Clark BC, Arnold WD (2021) Profiling age-related muscle weakness and wasting: neuromuscular junction transmission as a driver of age-related physical decline. GeroScience 43(3):1265–1281. https://doi.org/10.1007/s11357-021-00369-3

doi: 10.1007/s11357-021-00369-3 pubmed: 33895959 pmcid: 8190265

Kurihara M, Bamba S, Yasuhara S, Itoh A, Nagao T, Nakanishi N, Nakamura R, Ogawa N, Kitamura A, Yamakawa I, Kim H, Sanada M, Urushitani M, Sasaki M (2021) Factors affecting energy metabolism and prognosis in patients with amyotrophic lateral sclerosis. Ann Nutr Metab 77(4):236–243. https://doi.org/10.1159/000518908

doi: 10.1159/000518908 pubmed: 34515052

Le Gall L, Duddy WJ, Martinat C, Mariot V, Connolly O, Milla V, Anakor E, Ouandaogo ZG, Millecamps S, Lainé J et al (2022) Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles. J Cachexia Sarcopenia Muscle 13(2):1385–1402. https://doi.org/10.1002/jcsm.12945

doi: 10.1002/jcsm.12945 pubmed: 35194965 pmcid: 8978001

Re Cecconi AD, Barone M, Gaspari S, Tortarolo M, Bendotti C, Porcu L, Terribile G, Piccirillo R (2022) The p97-Nploc4 ATPase complex plays a role in muscle atrophy during cancer and amyotrophic lateral sclerosis. J Cachexia Sarcopenia Muscle. https://doi.org/10.1002/jcsm.13011

doi: 10.1002/jcsm.13011 pubmed: 35611892 pmcid: 9397562

Sarcopenia and nervous system disorders.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Pagination

Informations de copyright

Références

Auteurs

Jie Yang (J)

Feifei Jiang (F)

Ming Yang (M)

Zhizhi Chen (Z)

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Smoking Cessation and Incident Cardiovascular Disease.

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Classifications MeSH